Tetracycline
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
100.00 |
|
11 |
No Use |
100.00 |
|
10 |
|
Ceftiofur
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Amoxicillin And Beta-Lactamase Inhibitor
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Ampicillin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
18.20 |
|
11 |
No Use |
10.00 |
|
10 |
|
Cefalotin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Amikacin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Cefoxitin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Ciprofloxacin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Gentamicin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Nalidixic Acid
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Sulfamethoxazole And Trimethoprim
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Chloramphenicol
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
0.00 |
|
10 |
|
Kanamycin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
0.00 |
|
11 |
No Use |
10.00 |
|
10 |
|
Streptomycin
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
90.90 |
|
11 |
No Use |
100.00 |
|
10 |
|
Sulfamethoxazole
/
|
Salmonella spp. (Typing Performed)
|
See: Table 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Continuous CTC Use |
81.80 |
|
11 |
No Use |
90.00 |
|
10 |
|